189 related articles for article (PubMed ID: 108745)
1. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
Miglécz E; Székely JI; Dunai-Kovács Z
Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
[TBL] [Abstract][Full Text] [Related]
2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
3. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.
Székely JI; Dunai-Kovács Z; Miglécz E; Rónai AZ; Bajusz S
J Pharmacol Exp Ther; 1978 Dec; 207(3):878-83. PubMed ID: 731437
[TBL] [Abstract][Full Text] [Related]
4. Behavioral activating effects of opiates and opioid peptides.
Browne RG; Segal DS
Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
[TBL] [Abstract][Full Text] [Related]
5. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
Brady LS; Holtzman SG
J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive activity of glycosidic enkephalin analogues.
Rodríguez RE; Rodríguez FD; Sacristán MP; Torres JL; Reig F; García Antón JM; Valencia G
Psychopharmacology (Berl); 1990; 101(2):222-5. PubMed ID: 2349363
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice.
Ueda H; Amano H; Shiomi H; Takagi H
Eur J Pharmacol; 1979 Jun; 56(3):265-8. PubMed ID: 582583
[TBL] [Abstract][Full Text] [Related]
8. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
Vaught JL; Rothman RB; Westfall TC
Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
Székely JI; Miglécz E; Rónai AZ
Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
[TBL] [Abstract][Full Text] [Related]
10. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
Tortella FC; Moreton JE; Khazan N
J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
[TBL] [Abstract][Full Text] [Related]
11. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
Wollemann M; Szebeni A; Bajusz S; Gráf L
Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
[TBL] [Abstract][Full Text] [Related]
12. Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia.
Chapman DB; Hu J; Way EL
Eur J Pharmacol; 1980 Aug; 65(4):369-77. PubMed ID: 7190925
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
Bhargava HN
Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.
Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE
Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748
[TBL] [Abstract][Full Text] [Related]
15. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
Vermes I; Szontágh L; Telegdy G
Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
[TBL] [Abstract][Full Text] [Related]
17. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
[TBL] [Abstract][Full Text] [Related]
18. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
19. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
Köves K; Marton J; Molnár J; Halász B
Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
[TBL] [Abstract][Full Text] [Related]
20. Opiate agonists inhibit neurogenic plasma extravasation in the rat.
Barthó L; Szolcsányi J
Eur J Pharmacol; 1981 Jul; 73(1):101-4. PubMed ID: 6172279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]